Correlation between Serum Magnesium and Parathyroid Hormone in Hemodialysis Patients. | ||
| Benha Medical Journal | ||
| Article 8, Volume 37, Special issue (Internal medicine and Hepatology), November 2020, Pages 91-98 PDF (997.99 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/bmfj.2020.105259 | ||
| Authors | ||
| Amir Mohammed El okely1; Ahmed Ghareeb Menshawy2; Mohamoud Hosny Zahran1 | ||
| 1Department of internal medicine, Faculty of Medicine, Zagazig University, Egypt. | ||
| 2Internal medicine,medicine,zagazig university,zagazig,egypt | ||
| Abstract | ||
| Background: It is considerable that chronic kidney disease–mineral bone disorder (CKD-MBD) is a vital issue in chronic kidney disease patients. Parathyroid hormone (PTH) is a fundamental factor in the pathogenesis of this disorder in dialysis patients. It is believed that plasma magnesium (Mg2+) has an essential role in the regulation of PTH secretion in a manner which is slightly similar to calcium. Objectives: Illustrates the relationship between serum magnesium and serum parathyroid hormone in hemodialysis patients. Patients and Methods: A cross-sectional study had been carried out in the Hemodialysis Unit, Zagazig University Hospitals, Faculty of medicine, Zagazig University from the period between December 2018 and May 2019. The study included (77) participants diagnosed with end stage renal disease on regular hemodialysis. Results: There is no statistically significant correlation between serum magnesium and serum parathyroid hormone. Conclusion: Our findings suggest that factors other than serum Mg may be more important in the regulation of PTH secretion and action. Our findings require further investigations with larger and multicentric studies. | ||
|
Statistics Article View: 366 PDF Download: 664 |
||
